Offering a new predoctoral position in our group

-March 2024:

A PREDOCTORAL CONTRACT ASSOCIATED WITH A PROJECT IN THE AREA OF BIOMEDICINE is offered to develop a research project related to the treatment of human heart models with biological therapies based on extracellular vesicles. You can join FIBROHEART to become a doctor studying the action of protein nanotherapies encapsulated in extracellular vesicles in anti- and profibrotic human heart organoids. Write to villarav@unican.es with your CV and your grade title and mean note.

-December 2023:

-Luisa Gutierrez Esteve, a master's student, is seeking the "Concepción Arenal" predoctoral grant in Biomedicine with our team. We extend our best wishes and look forward to welcoming you to the group in the coming months.

-November 2023:

-Today 22 of november 2023, interview with media to talk about our last published paper.Fibroblast-derived extracellular vesicles as trackable efficient transporters of an experimental nanodrug with fibrotic heart and lung targeting.

Published in Theranostics 2024, Vol. 14, Issue 1 Ahead of print.

-A new predoctoral position is now available in our research group. Join FIBROHEART for the opportunity to pursue your Ph.D. in the field of myocardial fibrosis. This exciting research involves the utilization of biotechnological nanodrugs in conjunction with the study of CRISPR/CAS deletion of a target gene in human cardiac organoids. Our aim is to identify the domain responsible for the suppression of detrimental fibrosis. If you are passionate about cutting-edge research in this field, we encourage you to apply and be a part of our innovative team.


If you are interested in joining our team, kindly send an email to villarav@unican.es.


-August 2023:

Hiring. New position in the group. One of our predoct student is aboout to finish, so we are now hiring a new predoct.


Thesis. the linkedin published offer is:

Se ofrece un CONTRATO-predoctoral que cubre todo el periodo de la realización de la tesis doctoral en Biomedicina  en el Instituto de Biomedicina y Biotecnología de Cantabria-UC.  La Tesis Doctoral se centra en el estudio de la reducción de la fibrosis cardíaca mediante la aplicación de herramientas biotecnológicas teragnósticas de última generación (nano transportadores y moléculas terapéuticas fluorescentes), mediante la aplicación de CRISPR/CAS en organoides 3D. 

 

Responsabilidades

La tesis se realizará en el grupo de investigación de la Dra Ana V. Villar en el Instituto de Biomedicina y Biotecnología de Cantabria. P ara más información visitar el blog del grupo (http://villarav.blogspot.com.es), las webs institucionales institucionales (https://web.unican.es/ibbtec/es-es/sobre-el-ibbtec/equipo/directorio/detalle-miembro?d=AnaVVillarLab)

https://web.unican.es/portal-investigador/personal-investigador/detalle-investigador?i=872B21A477B1E66C y las redes sociales https://www.youtube.com/channel/UCbHijFhTtHnB7-YeRHUNVrA  

https://twitter.com/fibrolab1

 

 

Los interesadas/os, enviar CV, copia del expediente académico, y una carta de motivación, a Ana V Villar, villarav@unican.es antes del 20 de septiembre 2023.

 

Requisitos

-      Se requiere tener un expediente académico de Grado superior a 8,5 en la escala de 1 a 10 y haber finalizador el máster.

-      Se requiere haber acabado el grado en 2020 o posterior.

-      Se requiere NO haber tenido un contrato predoctoral de duración superior a 1 año.

 

Se valorará la experiencia previa en laboratorio, el dominio del inglés, las estancias en el extranjero. La entrevista personal on line que se realizará con los candidatos preseleccionados.


-July 2023:

- New paper published by our group in collaboration with Maria Blasco´s group:

Short telomeres in alveolar type II cells associate with lung fibrosis in post COVID-19 patients with cancer.

-We are part of the new spanish REDFIBRO a network of different scientific groups that study fibrosis in Spain. AEI approved our NET. Congratulations for the obtention of  RED DE INVESTIGACION INTEGRADA EN FIBROSIS ORGANICARED (RED2022-134485-T). Call  “REDES DE INVESTIGACIÓN” AEI


-Abstract accepted for the SEBBM congress in Zaragoza 5-8 september, where We organize a Simposium about nanomedicine


-June 2023: 

Great Escuela de Verano UIMP in Nanomedicine. As director of this course I would like to thank all students for their great work and interaction with us.


 -March 2023:

-We have been approved as members of the COST Action Sudden cardiac arrest prediction and resuscitation network: Improving the quality of care (PARQ)

-JJ Sanguilan will be our new student from Mexico visiting us during summer with a summer grant. Congratulations and wellcome.


-January 2023:

We are offering in collaboration with Dr. Isabel Varela at the Instituto Alberto Sols Madrid a PhD thesis on the study of advanced nanotherapies for the treatment of vestibular schawnnoma focused on the communication between Schwann cells and fibroblasts in human cells.
Master students with degree mark above 8.0 will be evaluated.
Send your CV to: villarav@unican.es

-Interview about the last paper nov 2023. Interview in farmaforum. European consortium . FibroHeart experiments at diamond and ALBA synchrotron facilities -predoctoral position offered -OpenLab grant and IFEMA presentation

                                                                   November 2023
News papers publishing our discoveries:
Infosalus: 
https://www.infosalus.com/asistencia/noticia-ibbtec-avanza-sistema-transportar-farmaco-experimental-tratamiento-fibrosis-20231129185028.html 
Cantabria economia:
https://www.cantabriaeconomica.com/empresas/el-ibbtec-disena-un-sistema-para-transportar-un-farmaco-experimental-contra-la-fibrosis/



Interview to Ana V Villar PI of FIBROHEART about the last scientific publication of her group:

                    


                 https://web.unican.es/noticias/Paginas/2023/11/nanofarmaco-experimental-fibrosis.aspx 

                    https://youtu.be/zFnNpQ1DJzI?si=jFEILgXhC4K1oPVD 


Fibroblast-derived extracellular vesicles as trackable efficient transporters of an experimental nanodrug with fibrotic heart and lung targeting. Published in Theranostics 2024, Vol. 14, Issue 1


                                                            December 2022
Interview to Ana V Villar PI of FIBROHEART in farmaforum magazine. Follow this link:

https://www.farmabiotec.com/revistas/numero-4-invierno-2022-2022



Ana V Villar director of a symposium accepted at the 45th SEBBM congress (Zaragoza 5-8 September 2023)


                                                        October 2022    

We are part of a european consortium that start with the partnership of 13 universities.

Fibroheart group was selected to belong to this european consortium

https://twitter.com/Nanomed_CSIC/status/1582318677235765250?t=b21vlnilPJHig_1fHeSQiw&s=19


                                                         September 2022

- Invitation to explain our research at the IFEMA Madrid Congress Health & Research forum  FARMA BIOTECH FARMAFORUM next month 

- Our FIBROHEAT group has been selected as a beneficiary of an OpenLab-CEO 2022 OpenLab-CEO grant. Thanks to this grant one of our projects will be oriented to patent some of our potential anti-fibrotic solutions. Congratulations to the group.

-We start an interesting collaboration with CSIC Madrid on organoids. Wellcome Esther.


-Predoctoral position is available for application from now until the end of September 2022. Write to villarav@unican.es with your CV, motivation letter and degree.




August 2022






 -Look at FibroHeart you tube chanel 

https://www.youtube.com/watch?v=W7d-fUEU22E 


-Predoctoral position available

Predoctoral position is available for application from now until September 2022. Write to villarav@unican.es with your CV, motivation letter and degree.

Look at the hiring section of this blog